Exhaled Breath Diagnostics of Lung and Gastric Cancers in China Using Nanosensors
Alaa Gharra,Yoav Y. Broza,Guiping Yu,Weidong Mao,Dong Shen,Lichun Deng,Wang Chun,Qiong Wang,Xia Sun,Jianming Huang,Xuan Zhang,Bing Huang,Song Wu,Yana Milyutin,Viki Kloper‐Weidenfeld,Hossam Haick
DOI: https://doi.org/10.1002/cac2.12030
IF: 15.2825
2020-01-01
Cancer Communications
Abstract:Dear Editor, Breath analysis is a promising diagnostic approach for various conditions [1, 2]. It is based on the identification of volatile organic compounds (VOCs) emitted in the breath, which creates a unique volatolomic signature [3]. Owing to their characteristics, VOCs can be measured non-intrusively from the breath or other body sources [3, 4]. Several studies have shown the diagnostic potential for a variety of conditions based on VOC analysis [5-9]. Malignant diseases, where early detection is crucial, are the main focus of VOC analysis, with lung cancer (LC) and gastric cancer (GC) being the most studied. LC and GC together were responsible for approximately 2.5 million deaths globally in 2018 [10]. The aim of VOC analysis of the breath using sensors is to identify a “VOC-print” comprising the total abundances and ratios of the compounds in the breath, giving an overall unique chemical pattern [11]. This technology can help to address specific challenges concerning LC screening and GC mortality [12,13]. To facilitate real-world applications, different ethnicand culture-based populations should be sampled. Here, we carried out a VOC-based clinical trial for GC and LC detection in China to classify these two major malignancies with different genetic and cultural backgrounds, using our developed sensors [1] with newly-developed sensor-printing and sampling methods. A total of 545 breath samples (one/two samples per subject) were collected from 426 adult participants between January 2018 and July 2019 at the Jiangyin Hospital Affiliated to the Southeast University Medical College in China. The study population consisted of three groups: LC patients (n = 158), GC patients (n = 115), and healthy volunteers (n = 153), as detailed in Table 1. All participants gave their informed consent for inclusion before participating in the study. Exhaled alveolar breath was collected in a controlled manner. End-tidal expired air was directly trapped and preconcentrated in Tenax TA sorption tubes (Buchem BV,